Variant report
Variant | rs6441963 |
---|---|
Chromosome Location | chr3:46354839-46354840 |
allele | C/T |
Outlinks | Ensembl   UCSC |
- TF binding region (count:31)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:31 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | STAT3 | chr3:46354281-46355155 | MCF10A-Er-Src | breast: | n/a | n/a |
2 | FOS | chr3:46354501-46354951 | MCF10A-Er-Src | breast: | n/a | chr3:46354615-46354624 |
3 | ELK1 | chr3:46354761-46354871 | Hela-S3 | cervix: | n/a | n/a |
4 | CEBPB | chr3:46354574-46354845 | K562 | blood: | n/a | chr3:46354701-46354712 |
5 | EP300 | chr3:46354449-46355076 | T-47D | breast: | n/a | n/a |
6 | STAT3 | chr3:46354481-46354861 | Hela-S3 | cervix: | n/a | n/a |
7 | POLR2A | chr3:46354460-46354880 | HL-60 | blood: | n/a | n/a |
8 | STAT3 | chr3:46354046-46355030 | MCF10A-Er-Src | breast: | n/a | n/a |
9 | FOS | chr3:46354352-46354995 | MCF10A-Er-Src | breast: | n/a | chr3:46354615-46354624 |
10 | ESR1 | chr3:46354629-46354992 | T-47D | breast: | n/a | n/a |
11 | STAT3 | chr3:46354281-46354998 | MCF10A-Er-Src | breast: | n/a | n/a |
12 | MAX | chr3:46354551-46354862 | Hela-S3 | cervix: | n/a | n/a |
13 | POLR2A | chr3:46354342-46354953 | HL-60 | blood: | n/a | n/a |
14 | CEBPB | chr3:46354458-46354965 | MCF-7 | breast: | n/a | chr3:46354701-46354712 |
15 | FOS | chr3:46354399-46354894 | MCF10A-Er-Src | breast: | n/a | chr3:46354615-46354624 |
16 | POLR2A | chr3:46354183-46354841 | MCF10A-Er-Src | breast: | n/a | n/a |
17 | MYC | chr3:46354354-46355114 | MCF10A-Er-Src | breast: | n/a | n/a |
18 | CEBPB | chr3:46354537-46354909 | MCF-7 | breast: | n/a | chr3:46354701-46354712 |
19 | EP300 | chr3:46354468-46355073 | T-47D | breast: | n/a | n/a |
20 | MYC | chr3:46354494-46354965 | MCF10A-Er-Src | breast: | n/a | n/a |
21 | STAT3 | chr3:46354303-46355089 | MCF10A-Er-Src | breast: | n/a | n/a |
22 | SPI1 | chr3:46354368-46354902 | HL-60 | blood: | n/a | n/a |
23 | GATA3 | chr3:46354481-46355087 | T-47D | breast: | n/a | n/a |
24 | FOXA1 | chr3:46354602-46355033 | T-47D | breast: | n/a | n/a |
25 | FOS | chr3:46354334-46355017 | MCF10A-Er-Src | breast: | n/a | chr3:46354615-46354624 |
26 | FOXA1 | chr3:46354544-46355043 | T-47D | breast: | n/a | n/a |
27 | MYC | chr3:46354505-46354841 | NB4 | blood: | n/a | n/a |
28 | GATA3 | chr3:46354463-46355116 | T-47D | breast: | n/a | n/a |
29 | CEBPB | chr3:46354478-46354905 | Hela-S3 | cervix: | n/a | chr3:46354701-46354712 |
30 | JUND | chr3:46354451-46355220 | T-47D | breast: | n/a | chr3:46354615-46354624 |
31 | MAFK | chr3:46354785-46354900 | HepG2 | liver: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
UQCRC2P1 | TF binding region |
rs_ID | r2[population] |
---|---|
rs10865940 | 0.95[AMR][1000 genomes];0.99[ASN][1000 genomes] |
rs11130089 | 0.95[AMR][1000 genomes];0.99[ASN][1000 genomes] |
rs11711054 | 0.93[AMR][1000 genomes];0.96[ASN][1000 genomes] |
rs13084656 | 0.85[CHB][hapmap];0.80[CHD][hapmap];0.90[JPT][hapmap] |
rs13096142 | 0.85[CHB][hapmap];0.86[CHD][hapmap];0.90[JPT][hapmap] |
rs1388604 | 0.90[JPT][hapmap] |
rs1799865 | 0.88[CEU][hapmap];0.85[JPT][hapmap];0.83[TSI][hapmap] |
rs2097282 | 0.80[ASN][1000 genomes] |
rs2157057 | 0.95[AMR][1000 genomes];0.98[ASN][1000 genomes] |
rs2157058 | 0.84[AMR][1000 genomes];0.82[ASN][1000 genomes] |
rs2157059 | 0.99[AFR][1000 genomes];0.92[AMR][1000 genomes];0.98[ASN][1000 genomes] |
rs2187669 | 0.84[AMR][1000 genomes];0.82[ASN][1000 genomes] |
rs2187670 | 0.80[AMR][1000 genomes];0.82[ASN][1000 genomes] |
rs2213291 | 0.95[AMR][1000 genomes];0.98[ASN][1000 genomes] |
rs2213292 | 0.99[AFR][1000 genomes];0.95[AMR][1000 genomes];0.98[ASN][1000 genomes] |
rs3092962 | 0.81[JPT][hapmap] |
rs3092963 | 0.88[CEU][hapmap];0.85[JPT][hapmap];0.83[TSI][hapmap] |
rs34148191 | 0.95[AMR][1000 genomes];0.98[ASN][1000 genomes] |
rs34193387 | 0.95[AMR][1000 genomes];0.98[ASN][1000 genomes] |
rs34505903 | 0.95[AMR][1000 genomes];0.97[ASN][1000 genomes] |
rs34997146 | 0.80[AMR][1000 genomes];0.80[ASN][1000 genomes] |
rs35053103 | 0.95[AMR][1000 genomes];0.98[ASN][1000 genomes] |
rs35465430 | 0.90[AFR][1000 genomes];0.95[AMR][1000 genomes];0.94[ASN][1000 genomes] |
rs35510257 | 0.80[AMR][1000 genomes];0.80[ASN][1000 genomes] |
rs35675823 | 0.95[AMR][1000 genomes];0.98[ASN][1000 genomes] |
rs35971655 | 0.95[AMR][1000 genomes];0.98[ASN][1000 genomes] |
rs36030342 | 0.95[AMR][1000 genomes];0.97[ASN][1000 genomes] |
rs36048784 | 0.84[AMR][1000 genomes];0.82[ASN][1000 genomes] |
rs3762823 | 0.81[JPT][hapmap] |
rs3918358 | 0.88[CEU][hapmap];0.85[JPT][hapmap];0.83[TSI][hapmap] |
rs4134396 | 0.86[AMR][1000 genomes];0.99[ASN][1000 genomes] |
rs4683198 | 0.87[ASN][1000 genomes] |
rs4683211 | 0.84[AMR][1000 genomes];0.82[ASN][1000 genomes] |
rs4683215 | 0.80[AMR][1000 genomes];0.83[ASN][1000 genomes] |
rs4683218 | 0.80[ASN][1000 genomes] |
rs62244813 | 0.84[AMR][1000 genomes];0.83[ASN][1000 genomes] |
rs62244827 | 0.99[AFR][1000 genomes];0.95[AMR][1000 genomes];0.98[ASN][1000 genomes] |
rs62244828 | 0.81[ASN][1000 genomes] |
rs62244840 | 0.95[AMR][1000 genomes];0.98[ASN][1000 genomes] |
rs62244848 | 0.88[AFR][1000 genomes];0.95[AMR][1000 genomes];0.97[ASN][1000 genomes] |
rs6441950 | 0.90[JPT][hapmap] |
rs6441953 | 0.87[ASN][1000 genomes] |
rs6441958 | 0.82[ASN][1000 genomes] |
rs6441959 | 0.80[AMR][1000 genomes];0.82[ASN][1000 genomes] |
rs6441960 | 0.84[AMR][1000 genomes];0.83[ASN][1000 genomes] |
rs6441961 | 0.95[AMR][1000 genomes];1.00[ASN][1000 genomes] |
rs6441962 | 0.95[AMR][1000 genomes];1.00[ASN][1000 genomes] |
rs6441964 | 0.92[AMR][1000 genomes];0.98[ASN][1000 genomes] |
rs6441971 | 0.81[JPT][hapmap] |
rs6767895 | 0.94[AMR][1000 genomes];0.99[ASN][1000 genomes] |
rs6771900 | 0.95[AMR][1000 genomes];1.00[ASN][1000 genomes] |
rs6775208 | 0.95[AMR][1000 genomes];1.00[ASN][1000 genomes] |
rs6783993 | 0.84[AMR][1000 genomes];0.82[ASN][1000 genomes] |
rs6785878 | 0.81[AMR][1000 genomes];0.94[ASN][1000 genomes] |
rs6788723 | 0.95[AMR][1000 genomes];1.00[ASN][1000 genomes] |
rs6794300 | 0.84[AFR][1000 genomes];0.93[AMR][1000 genomes];0.97[ASN][1000 genomes] |
rs71615444 | 0.86[ASN][1000 genomes] |
rs7371987 | 0.90[JPT][hapmap] |
rs7372094 | 0.93[AMR][1000 genomes];0.97[ASN][1000 genomes] |
rs7374654 | 0.93[AMR][1000 genomes];0.96[ASN][1000 genomes] |
rs7374671 | 0.89[AMR][1000 genomes];0.96[ASN][1000 genomes] |
rs7432080 | 0.80[AMR][1000 genomes];0.82[ASN][1000 genomes] |
rs7612940 | 0.80[AMR][1000 genomes];0.83[ASN][1000 genomes] |
rs7626249 | 0.95[AMR][1000 genomes];0.98[ASN][1000 genomes] |
rs7634816 | 0.95[AMR][1000 genomes];0.99[ASN][1000 genomes] |
rs7635588 | 0.84[AMR][1000 genomes];0.82[ASN][1000 genomes] |
rs963045 | 0.95[AMR][1000 genomes];0.98[ASN][1000 genomes] |
rs9813756 | 0.88[AFR][1000 genomes];0.95[AMR][1000 genomes];1.00[ASN][1000 genomes] |
rs9818053 | 0.95[AMR][1000 genomes];0.99[ASN][1000 genomes] |
rs9842716 | 0.85[CHB][hapmap];0.90[JPT][hapmap] |
rs9852052 | 0.84[AFR][1000 genomes];0.93[AMR][1000 genomes];0.97[ASN][1000 genomes] |
rs9853223 | 0.85[CHB][hapmap];0.80[CHD][hapmap];0.90[JPT][hapmap] |
rs9856098 | 0.95[AMR][1000 genomes];1.00[ASN][1000 genomes] |
rs9875668 | 0.95[AMR][1000 genomes];0.99[ASN][1000 genomes] |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | nsv876734 | chr3:45725031-46468467 | Weak transcription Enhancers Active TSS Flanking Active TSS Genic enhancers Bivalent/Poised TSS Strong transcription Bivalent Enhancer Flanking Bivalent TSS/Enh ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 42 gene(s) | inside rSNPs | diseases |
2 | esv3323840 | chr3:46352348-46497196 | Strong transcription Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Active TSS Genic enhancers Bivalent/Poised TSS ZNF genes & repeats Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 10 gene(s) | inside rSNPs | diseases |
3 | esv3389382 | chr3:46352798-46496696 | Enhancers ZNF genes & repeats Weak transcription Bivalent Enhancer Flanking Active TSS Transcr. at gene 5' and 3' Genic enhancers Bivalent/Poised TSS Strong transcription Active TSS Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 10 gene(s) | inside rSNPs | diseases |
No data |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:46350800-46367600 | Enhancers | Primary monocytes fromperipheralblood | blood |
2 | chr3:46352400-46355600 | Flanking Active TSS | Monocytes-CD14+_RO01746 | blood |
3 | chr3:46352600-46358000 | Weak transcription | Spleen | Spleen |
4 | chr3:46353800-46355000 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
5 | chr3:46353800-46355000 | Enhancers | Primary neutrophils fromperipheralblood | blood |
6 | chr3:46353800-46355600 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
7 | chr3:46354000-46356800 | Weak transcription | Primary Natural Killer cells fromperipheralblood | blood |
8 | chr3:46354400-46355000 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
9 | chr3:46354400-46356000 | Weak transcription | Primary B cells from cord blood | blood |